Have a feature idea you'd love to see implemented? Let us know!

MNKD Mannkind Corp

Price (delayed)

$6.85

Market cap

$1.89B

P/E Ratio

85.63

Dividend/share

N/A

EPS

$0.08

Enterprise value

$2.31B

MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, its ...

Highlights
Mannkind's net income has soared by 169% YoY and by 84% from the previous quarter
Mannkind's EPS has soared by 167% YoY and by 60% from the previous quarter
The company's debt rose by 26% YoY and by 2.3% QoQ

Key stats

What are the main financial stats of MNKD
Market
Shares outstanding
275.78M
Market cap
$1.89B
Enterprise value
$2.31B
Valuations
Price to book (P/B)
N/A
Price to sales (P/S)
7.05
EV/EBIT
37.89
EV/EBITDA
33.54
EV/Sales
8.64
Earnings
Revenue
$267.2M
Gross profit
$192.14M
Net income
$21.57M
EBIT
$60.89M
EBITDA
$68.79M
Free cash flow
$28.87M
Per share
EPS
$0.08
EPS diluted
$0.08
Free cash flow per share
$0.1
Book value per share
-$0.76
Revenue per share
$0.97
TBVPS
$1.66
Balance sheet
Total assets
$464.2M
Total liabilities
$674.13M
Debt
$481.42M
Equity
-$209.93M
Working capital
$255.56M
Liquidity
Debt to equity
-2.29
Current ratio
4.54
Quick ratio
3.75
Net debt/EBITDA
6.08
Margins
EBITDA margin
25.7%
Gross margin
71.9%
Net margin
8.1%
Operating margin
21.4%
Efficiency
Return on assets
4.6%
Return on equity
N/A
Return on invested capital
8.5%
Return on capital employed
15.5%
Return on sales
22.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNKD stock price

How has the Mannkind stock price performed over time
Intraday
8.73%
1 week
4.74%
1 month
-0.44%
1 year
105.09%
YTD
88.19%
QTD
8.9%

Financial performance

How have Mannkind's revenue and profit performed over time
Revenue
$267.2M
Gross profit
$192.14M
Operating income
$57.25M
Net income
$21.57M
Gross margin
71.9%
Net margin
8.1%
Mannkind's net income has soared by 169% YoY and by 84% from the previous quarter
The company's net margin has surged by 146% YoY and by 72% QoQ
Mannkind's gross profit has soared by 66% YoY and by 9% from the previous quarter
The revenue has soared by 51% YoY and by 8% from the previous quarter

Growth

What is Mannkind's growth rate over time

Valuation

What is Mannkind stock price valuation
P/E
85.63
P/B
N/A
P/S
7.05
EV/EBIT
37.89
EV/EBITDA
33.54
EV/Sales
8.64
Mannkind's EPS has soared by 167% YoY and by 60% from the previous quarter
The equity has increased by 17% year-on-year and by 7% since the previous quarter
The revenue has soared by 51% YoY and by 8% from the previous quarter
The P/S is 26% higher than the last 4 quarters average of 5.6 but 25% lower than the 5-year quarterly average of 9.4

Efficiency

How efficient is Mannkind business performance
The ROA has soared by 145% YoY and by 70% QoQ
Mannkind's ROS has increased by 21% from the previous quarter
The company's return on invested capital rose by 18% QoQ

Dividends

What is MNKD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNKD.

Financial health

How did Mannkind financials performed over time
The company's total assets is 31% lower than its total liabilities
Mannkind's quick ratio has surged by 122% YoY and by 10% QoQ
The company's current ratio has surged by 94% YoY and by 12% QoQ
The debt to equity has dropped by 51% year-on-year and by 10% since the previous quarter
The company's debt rose by 26% YoY and by 2.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.